retatrutide with or without food Efficacy and safety of retatrutide, a GIP, GLP-1, and glucagon receptor agonist, in people type 2 diabetes and inadequate glycaemic control with diet and exercise (TRANSCEND-T2D-1): a double-blind, randomised, phase 3 Reta clinical trial data &

The Tokyo White collection supports day-to-day face and body care without harsh cleansers or heavy residue

IGF-1 LR3 1 is a modified version of native IGF-1 that contains an arginine substitution at position 3 and a 13-amino-acid extension at the N-terminus

Mean age was 42 years, and mean disease duration was 16 years

Brighten and even your skin tone with the Luminous Glutathione Brightening Peel Off Mask

No new safety concerns emerged during the trial

It also promotes insulin-independent Y1-R-mediated glucose uptake in muscle tissue ex vivo and more profound reductions in food intake and body weight than liraglutide when administered to diet-induced obese rats